Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Successful major and minor surgery using factor VIII inhibitor bypassing activity in patients with haemophilia A and inhibitors.

Lauroua P, Ferrer AM, Guérin V.

Haemophilia. 2009 Nov;15(6):1300-7. doi: 10.1111/j.1365-2516.2008.01873.x. Epub 2009 Jul 29.

PMID:
19659794
2.

FEIBA in treatment of acute bleeding episodes in patients with haemophilia A and factor VIII inhibitors: a retrospective survey in regional haemophilia centre.

Smejkal P, Brabec P, Matyskova M, Bulikova A, Slechtova M, Kissova J, Chlupova G, Muzik J, Penka M.

Haemophilia. 2009 May;15(3):743-51. doi: 10.1111/j.1365-2516.2009.02012.x.

PMID:
19432925
3.

Experience of four UK comprehensive care centres using FEIBA® for surgeries in patients with inhibitors.

Rangarajan S, Yee TT, Wilde J.

Haemophilia. 2011 Jan;17(1):28-34. doi: 10.1111/j.1365-2516.2010.02360.x.

PMID:
20642787
4.

Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey.

Zülfikar B, Aydogan G, Salcioglu Z, Oner AF, Kavakli K, Gursel T, Zülfikar H; FEIBA Investigators Team..

Haemophilia. 2012 May;18(3):383-91. doi: 10.1111/j.1365-2516.2011.02693.x. Epub 2011 Nov 22.

PMID:
22103429
5.

FEIBA in the treatment of acquired haemophilia A: results from the prospective multicentre French 'FEIBA dans l'hémophilie A acquise' (FEIBHAC) registry.

Borg JY, Négrier C, Durieu I, Dolimier E, Masquelier AM, Lévesque H; FEIBHAC Study Group..

Haemophilia. 2015 May;21(3):330-7. doi: 10.1111/hae.12574. Epub 2014 Oct 31.

PMID:
25359571
6.

SURgical interventions with FEIBA (SURF): international registry of surgery in haemophilia patients with inhibitory antibodies.

Négrier C, Lienhart A, Numerof R, Stephens D, Wong WY, Baghaei F, Yee TT.

Haemophilia. 2013 May;19(3):e143-50. doi: 10.1111/hae.12080. Epub 2013 Jan 3.

PMID:
23282031
7.

Randomized comparison of prophylaxis and on-demand regimens with FEIBA NF in the treatment of haemophilia A and B with inhibitors.

Antunes SV, Tangada S, Stasyshyn O, Mamonov V, Phillips J, Guzman-Becerra N, Grigorian A, Ewenstein B, Wong WY.

Haemophilia. 2014 Jan;20(1):65-72. doi: 10.1111/hae.12246. Epub 2013 Aug 1.

8.

Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia.

Martinowitz U, Luboshitz J, Bashari D, Ravid B, Gorina E, Regan L, Stass H, Lubetsky A.

Haemophilia. 2009 May;15(3):676-85. doi: 10.1111/j.1365-2516.2008.01978.x. Epub 2009 Feb 27.

PMID:
19298381
9.

Prophylaxis with FEIBA in paediatric patients with haemophilia A and inhibitors.

Ewing N, Escuriola-Ettingshausen C, Kreuz W.

Haemophilia. 2015 May;21(3):358-64. doi: 10.1111/hae.12602. Epub 2015 Jan 21.

PMID:
25603840
10.
11.

The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series.

Valentino LA.

Haemophilia. 2009 May;15(3):733-42. doi: 10.1111/j.1365-2516.2009.01980.x. Epub 2009 Feb 23.

PMID:
19298380
12.
13.

Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review.

Kraut EH, Aledort LM, Arkin S, Stine KC, Wong WY.

Haemophilia. 2007 Sep;13(5):508-17.

PMID:
17880437
14.

Surgery in patients with haemophilia and high responding inhibitors: Izmir experience.

Balkan C, Karapinar D, Aydogdu S, Ozcan C, Ay Y, Akin M, Kavakli K.

Haemophilia. 2010 Nov;16(6):902-9. doi: 10.1111/j.1365-2516.2010.02329.x.

PMID:
20518817
16.

Consensus recommendations for the use of FEIBA(®) in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery.

Rangarajan S, Austin S, Goddard NJ, Négrier C, Rodriguez-Merchan EC, Stephensen D, Yee TT.

Haemophilia. 2013 Mar;19(2):294-303. doi: 10.1111/hae.12028. Epub 2012 Sep 19. Review.

PMID:
22989234
17.

Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX.

Tjønnfjord GE, Brinch L, Gedde-Dahl T, Brosstad FR.

Haemophilia. 2004 Mar;10(2):174-8.

PMID:
14962207
18.

Factor VIII inhibitor bypassing activity (FEIBA) - addressing safety issues.

Aledort LM.

Haemophilia. 2008 Jan;14(1):39-43. Epub 2007 Oct 22. Review.

PMID:
17961169
19.

Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors.

Valentino LA.

Haemophilia. 2010 Mar;16(2):263-71. doi: 10.1111/j.1365-2516.2009.02126.x. Epub 2009 Dec 16.

PMID:
20028421
20.

A retrospective postlicensure survey of FEIBA efficacy and safety.

Dimichele D, Négrier C.

Haemophilia. 2006 Jul;12(4):352-62.

PMID:
16834734

Supplemental Content

Support Center